Job Opportunities
Find jobs near you, whether onsite, hybrid, or remote.- Similar Jobs to: Facilities Manager - Cannock
Facilities Manager - Oxford
ImmunocoreCuddesdon
Facilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSuttonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCowleyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSwinfordFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocorePeasemoreFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBixFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEastleach MartinFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreIdburyFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreOvingFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreHook NortonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreUpper BasildonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreEastleach TurvilleFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGreat BarringtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreCornwellFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreAddingtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreShrivenhamFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreAdstockFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreShalstoneFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreIdstoneFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreBroughtonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreWelfordFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreSwanbourneFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGreat HorwoodFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreNethertonFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
Facilities Manager - Oxford
ImmunocoreGreatworthFacilities Manager - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transfor
